ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dysport® Adult Lower Limb Spasticity Study

ClinicalTrials.gov ID: NCT01249404

Public ClinicalTrials.gov record NCT01249404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicentre, Double-blind, Prospective, Randomized, Placebo-controlled Study, Assessing the Efficacy and Safety of Dysport® Used for the Treatment of Lower-limb Spasticity in Adult Subjects With Hemiparesis Due to Stroke or Traumatic Brain Injury

Study identification

NCT ID
NCT01249404
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ipsen
Industry
Enrollment
388 participants

Conditions and interventions

Conditions

Interventions

  • Botulinum toxin type A Biological
  • Placebo Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Nov 30, 2013
Completion
Apr 30, 2014
Last update posted
Sep 27, 2022

2011 – 2014

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
Mayo Clinic Arizona Scottsdale Arizona 85259
Rancho Los Amigos Downey California 90242
Pacific Neuroscience Medical Group Oxnard California 93030
Associated Neurologists of Southern CT, PC Fairfield Connecticut 06824
Parkinson's Disease & Movement Disorders Center of Boca Raton Boca Raton Florida 33486
Design Neuroscience Miami Gardens Florida 33169
Mount Sinai School of Medicine New York New York 10029
Weill Cornell Medical College New York New York 10065
University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7200
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157
MossRehab & Albert Einstein Elkins Park Pennsylvania 19027
Vanderbilt University Nashville Tennessee 37232
The University of Texas Southwestern Medical Center at Dallas Dallas Texas 75390-9016
University of North Texas HSC at Ben Hogan Center Fort Worth Texas 76104
Neurorehabilitation Specialist Houston Texas 66211
University of Texas - Houston Houston Texas 77030
University of Utah School of Medicine Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01249404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2022 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01249404 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →